Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 866 entries
View as:

A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00888693 Org: User:
Start: 11/30/08 End: - Due: -

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03000257 Org: User:
Start: 12/14/16 End: 03/29/22 Due: 03/29/23

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

Phase: N/A Priority: Normal
NCT ID: NCT06858813 Org: User:
Start: 04/14/25 End: 09/30/30 Due: 09/30/31

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03539536 Org: User:
Start: 10/10/18 End: 10/06/25 Due: 10/06/26

Expanded Access to Venetoclax

Phase: N/A Priority: Normal
NCT ID: NCT03123029 Org: User:
Start: - End: - Due: -

Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASD

Phase: N/A Priority: Normal
NCT ID: NCT05439616 Org: User:
Start: 07/07/22 End: 10/04/24 Due: 10/04/25

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN

Phase: N/A Priority: Normal
NCT ID: NCT03386513 Org: User:
Start: 01/02/18 End: 12/30/26 Due: 12/30/27

A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart Review

Phase: N/A Priority: Normal
NCT ID: NCT06362031 Org: User:
Start: 06/01/23 End: 04/30/24 Due: 04/30/25

A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01484990 Org: User:
Start: 04/30/10 End: 09/30/10 Due: 09/30/11

Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02442258 Org: User:
Start: 03/31/15 End: 12/31/15 Due: 12/31/16

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Phase: N/A Priority: Normal
NCT ID: NCT04041050 Org: User:
Start: 11/08/19 End: 12/31/26 Due: 12/31/27

A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT03089944 Org: User:
Start: 04/28/17 End: 11/08/19 Due: 11/08/20

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05139602 Org: User:
Start: 12/28/21 End: 01/31/26 Due: 01/31/27

Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00650156 Org: User:
Start: 06/30/07 End: - Due: -

A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)

Phase: N/A Priority: Normal
NCT ID: NCT03033511 Org: User:
Start: 02/07/17 End: 11/20/19 Due: 11/20/20

Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01412021 Org: User:
Start: 07/01/11 End: 04/02/18 Due: 04/02/19

Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02381444 Org: User:
Start: 04/17/15 End: 01/07/20 Due: 01/07/21

A Study to Assess Safety and Effectiveness of Injections of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Change of Mid-Face Volume

Phase: N/A Priority: Normal
NCT ID: NCT06734351 Org: User:
Start: 12/16/24 End: 07/31/29 Due: 07/31/30

A Study to Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03311477 Org: User:
Start: 11/06/17 End: 03/04/19 Due: 03/04/20

Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea

Phase: N/A Priority: Normal
NCT ID: NCT03925441 Org: User:
Start: 06/25/19 End: 08/06/19 Due: 08/06/20

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT03006068 Org: User:
Start: 01/31/17 End: 07/31/27 Due: 07/31/28

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

Phase: N/A Priority: Normal
NCT ID: NCT03539744 Org: User:
Start: 10/22/18 End: 11/30/27 Due: 11/30/28

A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02087878 Org: User:
Start: 03/31/14 End: 09/30/19 Due: 09/30/20

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02220738 Org: User:
Start: 09/30/14 End: 03/31/16 Due: 03/31/17

A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)

Phase: N/A Priority: Normal
NCT ID: NCT02265237 Org: User:
Start: 10/28/14 End: 04/07/17 Due: 04/07/18